| Primary |
| Diabetes Mellitus |
40.1% |
| Type 2 Diabetes Mellitus |
19.4% |
| Type 1 Diabetes Mellitus |
14.0% |
| Product Used For Unknown Indication |
6.4% |
| Hypertension |
5.1% |
| Cardiac Disorder |
2.6% |
| Blood Pressure |
2.3% |
| Blood Pressure Abnormal |
1.3% |
| Blood Cholesterol |
1.0% |
| Pain |
1.0% |
| Blood Cholesterol Abnormal |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Fluid Retention |
0.8% |
| Gestational Diabetes |
0.8% |
| Glaucoma |
0.8% |
| Hypothyroidism |
0.8% |
| Thyroid Disorder |
0.8% |
| Anticoagulant Therapy |
0.5% |
| Anxiety |
0.5% |
| Blood Disorder |
0.5% |
|
| Visual Acuity Reduced |
12.1% |
| Visual Impairment |
12.1% |
| Blood Glucose Increased |
8.8% |
| Myocardial Infarction |
6.6% |
| Renal Disorder |
5.5% |
| Weight Decreased |
5.5% |
| Incorrect Dose Administered |
4.4% |
| Malaise |
4.4% |
| Pneumonia |
4.4% |
| Cerebrovascular Accident |
3.3% |
| Death |
3.3% |
| Hospitalisation |
3.3% |
| Hypoglycaemia |
3.3% |
| Medication Error |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Tremor |
3.3% |
| Underdose |
3.3% |
| Urinary Tract Infection |
3.3% |
| Weight Increased |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
|
| Secondary |
| Diabetes Mellitus |
32.4% |
| Type 2 Diabetes Mellitus |
20.6% |
| Type 1 Diabetes Mellitus |
18.7% |
| Gestational Diabetes |
3.9% |
| Blood Pressure |
3.7% |
| Depression |
2.8% |
| Hypertension |
2.5% |
| Cardiac Disorder |
2.0% |
| Blood Glucose Increased |
1.9% |
| Thyroid Disorder |
1.7% |
| Anaesthesia |
1.6% |
| Induction Of Anaesthesia |
1.6% |
| Asthma |
1.2% |
| Blood Cholesterol |
1.1% |
| Anxiety |
0.9% |
| Blood Pressure Abnormal |
0.9% |
| Blood Cholesterol Increased |
0.6% |
| Breast Cancer |
0.6% |
| Erysipelas |
0.6% |
| Nervous System Disorder |
0.6% |
|
| Hypoglycaemia |
7.9% |
| Visual Acuity Reduced |
7.9% |
| Visual Impairment |
7.9% |
| Weight Increased |
7.1% |
| Incorrect Dose Administered |
6.3% |
| Infarction |
6.3% |
| Premature Baby |
5.5% |
| Varicella |
5.5% |
| Wrong Technique In Drug Usage Process |
5.5% |
| Injection Site Bruising |
3.9% |
| Myocardial Infarction |
3.9% |
| Pain |
3.9% |
| Pallor |
3.9% |
| Underdose |
3.9% |
| Weight Decreased |
3.9% |
| Wrong Drug Administered |
3.9% |
| Pericardial Effusion |
3.1% |
| Pneumonia |
3.1% |
| Retinal Haemorrhage |
3.1% |
| Thrombosis |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
78.4% |
| Rheumatoid Arthritis |
5.9% |
| Type 1 Diabetes Mellitus |
3.9% |
| Diabetes Mellitus |
2.0% |
| Hypertension |
2.0% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
2.0% |
| Osteoporosis |
2.0% |
| Stress Urinary Incontinence |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
|
| Blood Glucose Increased |
14.3% |
| Death |
14.3% |
| Ischaemic Stroke |
14.3% |
| Pain |
14.3% |
| Road Traffic Accident |
14.3% |
| Tongue Oedema |
14.3% |
| Viral Infection |
14.3% |
|
